These include patients with DCIS, multifocal tumors, lobular histology, presence of extensive intraductal component, axillary lymph node metastasis, HER2 amplification, tumor size, lower quadrant tumors, and microcalcifications on mammography [11-13]. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.